Menopause Timing Influences Frailty Progression in Women

Strategic Insights -

A recent study conducted by researchers at the Affiliated Suzhou Hospital of Nanjing Medical University has shed light on the impact of menopause timing on the longitudinal progression of frailty among Chinese middle-aged and older women. The prospective cohort study, which utilized data from the China Health and Retirement Longitudinal Study from 2011 to 2018, found that women who experienced menopause after age 55 exhibited the fastest frailty progression compared to those who underwent menopause at age 50-55. The study also found that premature ovarian insufficiency was associated with accelerated frailty progression.

Key Takeaways:

  • Women who experienced menopause after age 55 had the fastest frailty progression compared to those who underwent menopause at age 50-55 (fully adjusted b = 0.43; 95 % confidence interval, 0.05 to 0.81; P = 0.027).
  • Women who underwent menopause at ages 40-44 also had a significantly accelerated frailty progression (b = 0.35; 95 % confidence interval, 0.07 to 0.64; P = 0.016).
  • The study highlights the need for early identification and targeted preventative interventions in women at risk of atypical menopause timing to promote healthy aging.
  • The research was conducted using data from the China Health and Retirement Longitudinal Study, which spans 2011 to 2018.
  • The study included a total of 11,984 women aged 45 years and older who experienced natural menopause.
  • The frailty index was calculated using 30 health deficits encompassing physical, cognitive, and psychological domains.

Statistics:

  • 11,984 women aged 45 years and older were included in the study.
  • Women who experienced menopause after age 55 had a frailty increase of 0.43 (95 % confidence interval, 0.05 to 0.81; P = 0.027).
  • Women who underwent menopause at ages 40-44 had a frailty increase of 0.35 (95 % confidence interval, 0.07 to 0.64; P = 0.016).
  • The study found that premature ovarian insufficiency was associated with accelerated frailty progression.

Sources:

  • Maturitas. "Age at menopause and the progression of frailty among middle-aged and older women: A prospective cohort analysis from CHARLS." October 2025; 202:108742.
  • Xinyue Zhang, Wei Yu, Yueqin Zhu, Runfei Zhang, and Yuhua Zhang. "Age at menopause and the progression of frailty among middle-aged and older women: A prospective cohort analysis from CHARLS." Maturitas. 2025; 202:108742.
  • NewsRx. "Researchers at Affiliated Suzhou Hospital of Nanjing Medical University Detail Findings in Menopause (Age at menopause and the progression of frailty among middle-aged and older women: A prospective cohort analysis from CHARLS)." OBGYN & Reproduction Week. October 20, 2025; p 873.